Inherited Bone Marrow Failure Panel
Use
This panel is designed for individuals who have relevant features or a clinical/suspected diagnosis of inherited bone marrow failure syndromes. It is also applicable for individuals with hematologic malignancies seeking to identify potential hereditary causes. By analyzing a broad range of genes, the test provides valuable insights into the genetic underpinnings of these conditions, aiding in diagnosis, risk assessment, and informed decision-making regarding patient management and family counseling.
Special Instructions
Not provided.
Limitations
The test is not cleared or approved by the FDA, but it follows CAP and CLIA regulations for validation. It may not detect all possible genetic variants related to bone marrow failure due to technical limitations or the current understanding of genetic contributions to the condition. Results should be interpreted with comprehensive clinical information for accurate assessment.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
No genes
Gene
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided